Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...

The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...